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Abstract
Introduction: The syndrome of fever is a commonly presenting complaint among persons seeking healthcare in low-
resource areas, yet the public health community has not approached fever in a comprehensive manner. In many areas,
malaria is over-diagnosed, and patients without malaria have poor outcomes.
Methods and Findings: We prospectively studied a cohort of 870 pediatric and adult febrile admissions to two hospitals in
northern Tanzania over the period of one year using conventional standard diagnostic tests to establish fever etiology.
Malaria was the clinical diagnosis for 528 (60.7%), but was the actual cause of fever in only 14 (1.6%). By contrast, bacterial,
mycobacterial, and fungal bloodstream infections accounted for 85 (9.8%), 14 (1.6%), and 25 (2.9%) febrile admissions,
respectively. Acute bacterial zoonoses were identified among 118 (26.2%) of febrile admissions; 16 (13.6%) had brucellosis,
40 (33.9%) leptospirosis, 24 (20.3%) had Q fever, 36 (30.5%) had spotted fever group rickettsioses, and 2 (1.8%) had typhus
group rickettsioses. In addition, 55 (7.9%) participants had a confirmed acute arbovirus infection, all due to chikungunya. No
patient had a bacterial zoonosis or an arbovirus infection included in the admission differential diagnosis.
Conclusions: Malaria was uncommon and over-diagnosed, whereas invasive infections were underappreciated. Bacterial
zoonoses and arbovirus infections were highly prevalent yet overlooked. An integrated approach to the syndrome of fever
in resource-limited areas is needed to improve patient outcomes and to rationally target disease control efforts.
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Introduction
Fever without a localized cause is one of the most common
presenting complaints among persons seeking healthcare in many
low- and middle-income countries [1,2]. However, unlike the
syndromes of pneumonia and diarrhea that feature in global
disease burden estimates and have well coordinated programs
integrating efforts across the range of responsible pathogens to
avert morbidity and mortality, there has been a lack of a
coordinated approach for febrile illness. While illness and death
due to some specific infections causing fever, such as malaria [3]
and increasingly bacterial sepsis are well quantified [4–6], others
such as a range of zoonoses and viral infections are uncounted and
consequently may be underappreciated.
The various etiologies of febrile illnesses are difficult to
distinguish from one another clinically [7,8]. As clinical laboratory
services are often limited in areas where febrile conditions are
particularly common [9,10], clinicians may have few diagnostic
tools to establish an etiologic diagnosis. Therefore, clinical
management is often driven by syndrome-based guidelines
employing empiric treatment [11–13]. In the absence of system-
atically collected data on fever etiology, considerable mismatch
between clinical diagnosis, clinical management, and actual
etiology may occur resulting in poor patient outcomes [14]. It is
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increasingly recognized that malaria is over-diagnosed in many
areas [14,15]. To address this problem, the World Health
Organization (WHO) malaria treatment guidelines moved away
from clinical diagnosis of malaria to treatment based on the results
of a malaria diagnostic test such as a blood smear or a malaria
rapid diagnostic test. With more widespread availability of
diagnostic tests to exclude malaria and apparent declines in
malaria worldwide [3], clinicians in resource-limited areas are
faced with a growing proportion of febrile patients who do not
have malaria and few tools to guide subsequent management.
We sought to describe comprehensively the causes of febrile
illness in northern Tanzania among patients sufficiently ill to
require hospitalization. Febrile patients admitted to two hospitals
were evaluated for a wide range of infectious etiologies using
conventional standard diagnostic techniques.
Methods
Ethics statement
This study was approved by the Kilimanjaro Christian Medical
Centre (KCMC) Research Ethics Committee, the Tanzania
National Institutes for Medical Research National Research Ethics
Coordinating Committee, and Institutional Review Boards of
Duke University Medical Center and the CDC. All minors had
written informed consent given from a parent or guardian and all
adult participants provided their own written informed consent.
Setting
Moshi (population, .144 000) is the administrative center of
the Kilimanjaro Region (population, .1.4 million) in northern
Tanzania and is situated at an elevation of 890 m above mean sea
level. The climate is characterized by a long rainy period (March–
May) and a short rainy period (October–December) [16]. Malaria
transmission intensity is low [17]. KCMC is a consultant referral
hospital with 458 inpatient beds serving several regions in
northern Tanzania, and Mawenzi Regional Hospital (MRH),
with 300 beds, is the Kilimanjaro Regional hospital. Together
KCMC and MRH serve as the main providers of hospital care in
the Moshi area. In 2008, KCMC admitted 22,099 patients and
MRH admitted 21,763 patients.
Study design
A study team that was independent of the hospital clinical team
identified participants among infants and children admitted to
KCMC from 17 September 2007 through 25 August 2008, and
among adolescents and adult admitted to KCMC and MRH in
Moshi, Tanzania, from 17 September 2007 through 31 August
2008. The methods of these studies have been described in detail
elsewhere [7,8]. In brief, all admitted patients were screened for
eligibility by study team members as soon as possible after
admission and no later than 24 hours after admission. Infants and
children aged from $2 months to ,13 years, with a history of
fever in the past 48 h or an axillary temperature $37.5uC or a
rectal temperature of $38.0uC, and adolescents and adults aged
$13 years and with oral temperatures of $38.0uC were invited to
participate in the study. Patients admitted with known malignancy,
renal failure, hepatic failure, bone marrow aplasia, trauma or
surgery were excluded.
A standardized clinical history and physical examination were
performed on consenting patients by a trained clinical officer who
was a member of the study team and who worked in parallel with
the hospital admitting team. Provisional diagnoses by the hospital
clinical team made independently of the study team were recorded
and coded using the International Statistical Classification of
Diseases and Related Health Problems, 10th Revision (ICD-10)
codes. Following cleansing of the skin with isopropyl alcohol and
povidone iodine, blood was drawn from adults and adolescents for
aerobic blood culture (5 mL) and for mycobacterial blood culture
(5 mL) and from pediatric patients for a single aerobic blood
culture (4 ml). In addition, blood was drawn for complete blood
count, examination for blood parasites, and HIV antibody testing.
Acute serum, plasma, and whole blood were archived on all
participants. For patients found to be HIV seropositive, CD4-
positive T lymphocyte count (CD4 cell count) and serum
cryptococcal antigen level were also measured. HIV-seronegative
patients were screened for the presence of acute HIV infection by
polymerase chain reaction (PCR) for HIV-1 RNA. Urine was
collected as soon as possible after admission for detection of urine
antimicrobial activity and for antigen detection. A discharge form
was completed at the time of discharge from the hospital that
captured whether the patient died in hospital, the in-hospital
management, and the discharge diagnoses coded using ICD-10
codes. The results of study investigations done in Moshi were
provided immediately to the hospital clinical team to inform
patient management. The results of investigations done at
reference laboratories were provided to the hospital clinical team
as they became available. The hospital clinical team was
responsible for all aspects of patient management, following
clinical judgment and use of locally adapted and developed
treatment guidelines. All participants were asked to return to a
study clinic 4–6 weeks after enrollment to provide a convalescent
serum sample. To promote high levels of follow up, the study team
provided a follow up appointment card prior to hospital discharge,
made reminder telephone calls to participants during the week
prior to the appointment, reimbursed travel expenses of returning
participants, and when necessary a field worker made home visits.
Laboratory evaluations
Laboratory evaluations were selected to reflect a range of
infectious diseases that might occur in northern Tanzania. Priority
was given to laboratory evaluations for infectious diseases that
might require specific management.
Malaria. Thick and thin blood films stained with Giemsa
were examined for blood parasites by oil immersion microscopy.
Parasite density was determined by standard methods [18].
Author Summary
The syndrome of fever is caused by a large number of
infectious diseases. Malaria is thought to have been
declining in the tropics since 2004. Increasing use of
malaria diagnostic tests reveal a growing proportion of
patients with fever who do not have malaria. While malaria
diagnostic tests may be available, healthcare workers have
few tools to diagnose causes of fever other than malaria. In
order to identify major causes of fever other than malaria
in northern Tanzania, we studied 870 patients with fever
who were sufficiently ill to require admission to hospital.
Malaria was uncommon and over-diagnosed, whereas
invasive infections, including bloodstream infections, were
underappreciated. Infections associated with animals such
as brucellosis, leptospirosis, Q fever, and spotted fever
group rickettsioses as well as viral infections transmitted
by mosquitoes were common yet overlooked. We recom-
mend that research on the syndrome of fever in resource-
limited areas should focus on a wide range of potential
causes. Animal-associated infections should be prioritized
in patient management and disease control.
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Bacteria and fungal bloodstream infections. Blood cul-
ture bottles were assessed for volume adequacy comparing the
weight before and after inoculation with blood. Adequate volume
was defined as the recommended volume 620%. BacT/ALERT
standard aerobic and mycobacterial bottles were loaded into the
BacT/ALERT 3D Microbial Detection system (BioMe´rieux),
where they were incubated for 5 and 42 days, respectively.
Standard methods were used for identifying bloodstream isolates
[7,8].
Serum antigen testing. Cryptococcal antigen level was
measured using the Latex Cryptococcal Antigen Detection System
assay (Immuno-Mycologics).
Urine antigen testing. Urine was tested for all participants
for Legionella pneumophila serogroup 1 antigen using the Binax
NOW Legionella urinary antigen test, and for adolescents and adults
using the Sreptococcus pneumoniae using the Binax NOW S. pneumoniae
antigen test (Binax). Urine was tested for Histoplasma capsulatum
antigen using the MVista H. capsulatum quantitative antigen
enzyme immunoassay (Miravista Diagnostics) [19,20].
Leptospirosis. Leptospirosis laboratory diagnosis was made
using the standard microscopic agglutination test (MAT) per-
formed at the CDC. Live leptospiral cell suspensions representing
20 serovars and 17 serogroups described elsewhere [21] were
incubated with serially diluted serum specimens. Resulting
agglutination titers were read using darkfield microscopy. The
reported titer was the highest dilution of serum that agglutinated at
least 50% of the cells for each serovar tested [22]. Confirmed
leptospirosis was defined as a $4-fold rise in the agglutination titer
between acute and convalescent serum samples [23].
Brucellosis. Brucellosis serology was performed using the
standard microagglutination test (MAT) performed at the CDC.
Standardized Brucella abortus strain 1119-3 killed antigen (National
Veterinary Services Laboratory, Ames, IA) was used for MAT at a
1:25 working dilution described elsewhere [24]. Results were read
on a Scienceware Plate Reader (Bel-Art Products, Wayne, NJ).
Minor modifications were made to the CDC’s standard MAT,
including the use of U-bottom plates, incubation at 26uC, and
discontinued use of staining techniques [25]. Confirmed brucel-
losis was defined as a $4-fold rise in the agglutination titer
between acute and convalescent serum samples.
Q fever. Convalescent-phase serum samples were screened
using C. burnetii immunoglobulin (Ig) G enzyme-linked immuno-
sorbent assay (ELISA) against Phase II antigen (Inverness Medical
Innovations). For samples that were either positive or equivocal by
ELISA, paired serum samples were tested by indirect immuno-
fluorescence antibody (IFA) IgG assay to C. burnetii (Nine Mile
strain) Phase I and Phase II antigens. A fourfold or greater increase
in IFA reciprocal titer to Phase II antigen defined acute Q fever
[26].
Spotted fever group and typhus group rickettsioses. Serum
samples were tested for SFGR and TGR by IgG IFA to R. conorii
(Moroccan strain) and to R. typhi (Wilmington strain), respectively.
Among paired serum samples, a fourfold or greater increase in IFA
titer to R. conorii and R. typhi defined acute SFGR and TGR
infections, respectively [26].
Arboviruses. RNA was extracted from serum samples using
the QIAamp Viral RNA Mini kit (QIAGEN, Hilden, Germany).
Reverse transcription was performed using Invitrogen Superscript
III First Strand Synthesis System (Life Technologies, Carlsbad,
CA). Real-time PCRs for flavivirus, DENV, and CHIKV were
carried out with the LightCycler 480 SYBR Green I Master kit
(Roche Diagnostics, Penzberg, Germany) in a total reaction
volume of 20 mL containing 2 mL of cDNA using primers
published elsewhere [27–29]. Confirmed acute CHIKV, DENV,
and flavivirus infections were defined as a positive PCR result for
CHIKV, DENV, and flavivirus viral RNA, respectively [30].
HIV. HIV-1 antibody testing was done on whole blood using
both the Capillus HIV-1/HIV-2 (Trinity Biotech) and Determine
HIV-1/HIV-2 (Abbott Laboratories) rapid HIV antibody tests.
The Capillus test was replaced with the SD Bioline HIV-1/HIV-2
test (version 3.0; Standard Diagnostics) on 4 March 2008 after a
change in Tanzania Ministry of Health HIV testing guidelines. If
rapid tests were discordant, the sample was tested using enzyme-
linked immunosorbent assay (ELISA; Vironostika Uni-Form II
plus O Ab; bioMe’rieux). If the ELISA was negative, no further
testing was done. If the ELISA was positive, a Western blot
(Genetic Systems HIV-1 Western blot kit; Bio-Rad) was done to
confirm the result [31]. HIV-1 RNA PCR was done using the
Abbott m2000 system RealTime HIV-1 assay (Abbott Laborato-
ries) [32,33].
Statistic analysis
Data were entered using the Cardiff Teleform system (Cardiff
Inc., Vista, Ca., USA) into an Access database (Microsoft Corp,
Va., USA). When a diagnostic test was not applied to the whole
cohort due lack of availability of an acute or convalescent sample,
the proportion of confirmed cases in the tested group was
extrapolated to the untested group by assuming that prevalence
was the same in the tested group as in the untested group.
Statistical analyses were performed with SAS version 9.1 software
(SAS Inc, Cary, NC).
Results
Participant characteristics
Figure 1 summarizes participant screening, enrollment, and
diagnostic testing. Of 870 febrile admissions to two hospitals in
northern Tanzania enrolled in the study 484 (55.6%) were female.
Of participants, 467 (53.7%) were infants and children with a
median (range) age of 2 years (2 months - 13 years); the remainder
adolescents and adults with a median (range) age of 38 (14–96)
years. Fifty seven (12.2%) infants and children were HIV-infected
compared with 157 (39.0%) adolescents and adults. Among infants
and children 34 (7.3%) of 464 with hospital outcome data died; 2
(5.9%) of those who died had invasive infections. Among
adolescents and adults, 41 (10.3%) of 398 with hospital outcome
data died; 11 (26.8%) of those who died had invasive infections. In
hospital deaths could not be attributed to etiologies requiring
serologic diagnosis due to the requirement for testing a convales-
cent serum sample.
Proportions of febrile admissions attributed to specific
etiologies
Table 1 shows the number of patients with acute and
convalescent samples available for testing for each etiologic agent
or group of etiologic agents. Not all tests could be applied to all
participants because of limited volumes of sample for some
participants, and by the lack of availability of convalescent serum
for participants who died before the follow up visit or who did not
return. The number of confirmed cases in each group is also
shown. The proportion of febrile admissions attributed to each
etiology is calculated. A complete sample set was available for
243–467 (52.0–100.0%) infants and children and for 207–403
(51.4–100.0%) adolescents and adults.
Etiology of fever among infants and children
Of 467 infants and children enrolled, malaria was the clinical
diagnosis for 282 (60.4%), but was the actual cause of fever in 6
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(1.3%). Bacterial and fungal bloodstream infections described in
detail elsewhere [8] accounted for 16 (3.4%) and 4 (0.9%) febrile
admissions, respectively, and were underrepresented on admission
differential diagnoses. Bacterial zoonoses were identified among 49
(20.2%) of febrile admissions; 5 (2.0%) had brucellosis, 19 (7.7%)
leptospirosis, 7 (2.6%) had Q fever, 18 (7.4%) had spotted fever
group rickettsioses, and none had typhus group rickettsioses. In
addition, 34 (10.2%) of participants had a confirmed acute
arbovirus infection, all due to chikungunya (Table 1). No patient
had a bacterial zoonoses or an arbovirus infection included in the
admission differential diagnosis.
Etiology of fever among adolescents and adults
Of 403 adolescents and adults enrolled, malaria was the clinical
diagnosis for 254 (63.0%), but was the actual cause of fever in 8
(2.0%). Bacterial, mycobacterial, and fungal bloodstream infec-
tions described in detail elsewhere [7] accounted for 69 (17.1%),
14 (3.5%), and 21 (5.2%) febrile admissions, respectively, and were
underrepresented on admission differential diagnoses. Bacterial
zoonoses were identified among 69 (33.3%) of febrile admissions;
11 (5.3%) had brucellosis, 21 (10.1%) leptospirosis, 17 (7.9%) had
Q fever, 18 (8.7%) had spotted fever group rickettsioses, and 2
(1.0%) had typhus group rickettsioses. In addition, 21 (5.7%) of
participants had a confirmed acute arbovirus infection, all due to
chikungunya (Table 1). No patient had a bacterial zoonosis or an
arbovirus infection included in the admission differential diagnosis.
Etiology of fever overall
Among all 870 participants, malaria was the clinical diagnosis
for 528 (60.7%), but was the actual cause of fever in 14 (1.6%). By
contrast, bacterial, mycobacterial, and fungal bloodstream
infections accounted for 85 (9.8%), 14 (1.6%), and 25 (2.9%)
febrile admissions, respectively, and were underrepresented on
admission differential diagnoses. Bacterial zoonoses were identified
among 118 (26.2%) of febrile admissions; 16 (13.6%) had
brucellosis, 40 (33.9%) leptospirosis, 24 (20.3%) had Q fever, 36
(30.5%) had spotted fever group rickettsioses, and 2 (1.8%) had
typhus group rickettsioses. In addition, 55 (7.9%) of participants
had a confirmed acute arbovirus infection, all due to chikungunya
(Table 1). No patient had a bacterial zoonoses or an arbovirus
infection included in the admission differential diagnosis. The
proportional etiology of febrile illness among study participants
after extrapolating to the untested group is summarized in
Figure 2.
Discussion
We demonstrate among hospitalized febrile patients in northern
Tanzania that malaria is uncommon and over-diagnosed, while
invasive bacterial, mycobacterial, and fungal infections are
underappreciated. At the same time, the bacterial zoonoses
leptospirosis, Q fever, and spotted fever rickettsioses, and to a
lesser extent brucellosis, and the arbovirus infection chikungunya
are common yet unrecognized causes of fever. Our findings point
to important mismatches between clinical diagnosis and manage-
ment with actual diagnoses that have major implications for
patient care, disease control and prevention, and for judicious use
of antimalarial medications.
While the problem of malaria over-diagnosis has been
appreciated for some time [14,15], studies that comprehensively
describe the causes of severe non-malaria fever requiring hospital
admission beyond bloodstream infections have been lacking. The
Figure 1. Study flow diagram. KCMC: Kilimanjaro Christian Medical Centre; MRH: Mawenzi Regional Hospital; MAT: microagglutination test; IFA:
immunoflouresence assay; NAAT: nucleic acid amplification test.
doi:10.1371/journal.pntd.0002324.g001
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over-diagnosis of malaria results in inappropriate use of antima-
larial medications and may be associated with higher case fatality
rates among patients treated for malaria who do not have the
infection [14,15,34]. While the underlying causes of the over-
diagnosis of malaria are complex [35], the lack of epidemiologic
information about the importance of alternative infections and
guidance on their management is likely to play a role. Our findings
confirm the potential benefits of making reliable malaria
diagnostic tests available at healthcare facilities and using the
results as the basis for prescription of antimalarial medications
[36]. When adopted, such an approach to malaria treatment
would support the judicious use of antimalarials and would define
the population of patients with nonmalaria fever.
We found that the bacterial zoonoses, leptospirosis, Q fever, and
spotted fever group rickettsioses, and to a lesser extent brucellosis,
are major causes of febrile illness among patients sufficiently
unwell to require hospitalization. That a group of neglected
bacterial zoonoses are of major clinical and public health
importance in sub-Saharan Africa is a new and paradigm-
changing finding. For clinical practice, with the exception of
leptospirosis that may be effectively treated with commonly
prescribed antibacterials, patients with brucellosis, Q fever, and
the rickettsioses are likely to leave hospital without specific
treatment. In northern Tanzania where many rely on livestock
for their health and economic wellbeing, Leptospira, Brucella, and
Coxiella spp. also indirectly affect human health through their
impact on animal fertility, growth, and survival. The control and
prevention of the neglected bacterial zoonoses is likely to involve
interventions that require the collaboration of human health
experts with the animal and environmental health disciplines, an
approach that is underdeveloped in many parts of the world.
Clinical guidelines for management of febrile patients in low
resource areas focus on the identification and treatment of malaria
and bacterial sepsis [11–13]. Our findings suggest that there is a
need to identify and incorporate guidance on when to use a
tetracycline for treatment of Q fever or rickettsial infection and
when to consider treatment for brucellosis. We have previously
demonstrated that features of the clinical history and physical
examination do not perform well for identifying fever etiology
[7,8,21,26,30]. Therefore, improvements to treatment algorithms
for febrile patients are likely to require the development and
incorporation of reliable diagnostic tests that provide timely
diagnostic information to clinicians [37]. Unfortunately, many
rapid diagnostic tests for infections related to fever management
other than malaria and HIV suffer from poor performance
characteristics [38,39].
Lack of coordination among groups working on the various
etiologies of febrile illness in low-resource areas has meant that
sentinel studies that could provide much more comprehensive
information on a wide range of responsible organisms instead have
focused on only one or a small handful of etiologies. For example,
a clinical trial evaluating the impact of pneumococcal conjugate
vaccine on rates of Streptococcus pneumoniae bacteremia in a
community has the potential to identify and report all bloodstream
infections. Similarly, a study designed to estimate the incidence of
typhoid fever to inform vaccine policy could collect acute serum
along with the blood culture and, with subsequent collection of
convalescent serum, would have the ability to estimate the
Table 1. Calculation of the proportion of hospitalized infants and children, and adolescents and adults, with specific etiologies of
febrile illness, northern Tanzania, 2007–8.
Etiology Infants and children Adults and adolescents All
n confirmed
cases n tested (%)
n confirmed
cases n tested (%)
n confirmed
cases n tested (%)
Bloodstream infections
Bacterial 16 467 (3.4) 69 403 (17.1) 85 870 (9.8)
Mycobacterial 0 467 (0.0) 14 403 (3.5) 14 870 (1.6)
Fungal 4 467 (0.9) 21 403 (5.2) 25 870 (2.9)
Malaria 6 467 (1.3) 8 403 (2.0) 14 870 (1.6)
Subtotal 26 467 (5.6) 112 403 (27.8) 138 870 (15.9)
Bacterial zoonoses
Brucellosis 5 246 (2.0) 11 207 (5.3) 16 453 (3.5)
Leptospirosis 19 246 (7.7) 21 207 (10.1) 40 453 (8.8)
Q fever 7 268 (2.6) 17 215 (7.9) 24 482 (5.0)
Spotted fever group rickettsioses 18 243 (7.4) 18 207 (8.7) 36 450 (8.0)
Typhus group rickettsioses 0 243 (0.0) 2 207 (1.0) 2 450 (0.4)
Subtotal 49 243 (20.2) 69 207 (33.3) 118 450 (26.2)
Arboviruses
Chikungunya 34 332 (10.2) 21 368 (5.7) 55 700 (7.9)
Flaviviruses 0 332 (0.0) 0 368 (0.0) 0 700 (0.0)
Subtotal 34 332 (10.2) 21 368 (5.7) 55 700 (7.9)
No diagnosis (64.0) (33.2) (50.1)
Due to changing denominators for individual diagnostic tests, the proportion with no diagnosis is calculated as the proportion without a positive result from any test.
Bloodstream infections are those diagnosed predominantly by blood culture, including organisms such as Salmonella enterica, Streptococcus pneumoniae, Cryptococcus
neoformans, and Mycobacterium tuberculosis. Bacterial zoonoses, including brucellosis, leptospirosis, Q fever, and rickettsioses were diagnosed predominantly by
serology, based on a 4-fold or greater rise in antibody titer between an acute and convalescent sample.
doi:10.1371/journal.pntd.0002324.t001
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incidence of leptospirosis and a range of other etiologic agents
using conventional serologic methods [40]. However, resources for
research have tended to be targeted to specific pathogens and
researchers have struggled to leverage additional resources to
address a broader range of organisms. Sentinel site studies seeking
to understand the infectious causes of febrile illness in low-resource
settings have utilized blood culture to highlight the importance of
invasive bacterial and fungal infections [4,41]. Expanding
laboratory evaluations to include serologic and molecular
approaches to diagnosing infections requiring specific antimicro-
bial management such as the bacterial zoonoses brucellosis,
leptospirosis, Q fever, and the rickettsioses adds considerable value
[40]. Detection of infections of public health importance such as
those caused by the arboviruses dengue, Rift Valley fever, and
yellow fever can inform national control programs. Since
considerable etiologic overlap exists between the syndromes of
fever, acute respiratory tract infection, and diarrhea [42,43],
addressing these simultaneously in integrated sentinel studies
would inform enhancements in empiric treatment guidelines and
improvements in the accuracy of syndrome-based disease burden
estimates.
Our study had a number of limitations. While we examined a
wide range of etiologies of fever, a large proportion of patients
were undiagnosed suggesting that we failed to identify potentially
important infections. The undiagnosed group is being investigated
further using pathogen discovery approaches. Some of the
diagnostic tests used in our study are less than 100% sensitive
and specific and we did not test for every known pathogen. As a
consequence, we probably underestimated the prevalence of some
infections while misclassifying others that were falsely positive.
Because a number of our diagnostic tests relied on the
demonstration of a four-fold rise in antibody titer between the
acute and convalescent serum sample, not all enrolled patients
returned for collection of convalescent serum to have diagnoses
confirmed. It follows that calculation and comparison of case
fatality rate was not possible since those who died before the
convalescent visit could not be confirmed cases. Incomplete
diagnostic information meant that we had to extrapolate
prevalence from the tested population to the untested population,
potentially introducing bias. Similarly, instances of apparent
infection with multiple agents were not accounted for in
presentation of pie graphs. Inclusion of a well control group
would have allowed the calculation of attributable fractions for
individual pathogens, something that should be considered for
future febrile illness research, especially in areas where malaria is
endemic. Since considerable geographic variation in fever etiology
is known to occur, the generalizability of our findings is uncertain.
What is needed to support an integrated approach to the
syndrome of fever in resource-limited areas? First, fever should be
recognized alongside pneumonia and diarrhea as a major clinical
syndrome of public health importance. Achieving this is likely to
require leadership from international institutions of public health
and reappraisal of the way that the febrile illnesses are approached
in burden of disease estimates. This could include estimating total
morbidity and mortality from the syndrome of fever as a first step
before attributing the associated illnesses and deaths to specific
etiologies, much as is done for the other major syndromes [44,45].
Second, efforts are needed to bring together the diverse groups
and disciplines currently working on the febrile illnesses to quantify
the morbidity and mortality attributable to each major etiologic
agent. Such integration could be facilitated by support for research
efforts that study the syndrome of fever comprehensively as well as
its etiologies individually, an approach that has been modeled by
studies addressing the syndromes of pediatric pneumonia and
diarrhea in developing countries [46,47]. Third, improved
diagnostic services are urgently needed to establish disease burden
estimates and patient management for the febrile illnesses in
resource-limited areas [10]. Conventional diagnostic tests for some
infections, such as leptospirosis, are complex. For example, the
collection of both acute and convalescent serum samples may be
required, and testing services may be available at only a few
national or supra-national reference laboratories. Assays relying on
convalescent samples cannot be used to estimate case fatality rates
[21,26]. Conversely, simple, rapid tests applied to acute samples
may have poor performance characteristics [38]. Finally, clinical
studies, including clinical trials, are needed to test and improve
clinical management algorithms for febrile patients. The goal
should be to target antimicrobial therapy to those who need it and
to avoid inappropriate use among patients who will not benefit. In
this way, patient outcomes can be improved, health resources can
be conserved, and disease prevention and control efforts for febrile
conditions can be rationally resourced.
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